Audio is streamed directly from the publisher (sphinx.acast.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Novo Nordisk reports that its GLP-1 drug Ozempic could help treat kidney disease. An advisory panel recommends the FDA approve Guardant Health’s colon cancer blood test. And Louisiana lawmakers vote to reclassify abortion pills as controlled dangerous substances. That’s coming up on today’s episode of Gist Healthcare Daily.
Hosted on Acast. See acast.com/privacy for more information.